Total Payments
$572,854
2024 Payments
$59,987
Companies
25
Transactions
956
Payment Breakdown by Category
Other$454,034 (79.3%)
Travel$66,039 (11.5%)
Consulting$31,733 (5.5%)
Food & Beverage$21,024 (3.7%)
Gifts$20.00 (0.0%)
Education$5.17 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $404,540 | 183 | 70.6% |
| Travel and Lodging | $66,039 | 309 | 11.5% |
| Honoraria | $49,494 | 25 | 8.6% |
| Consulting Fee | $31,733 | 11 | 5.5% |
| Food and Beverage | $21,024 | 426 | 3.7% |
| Gift | $20.00 | 1 | 0.0% |
| Education | $5.17 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Supernus Pharmaceuticals, Inc. | $270,921 | 324 | $0 (2024) |
| IRONSHORE PHARMACEUTICALS INC. | $160,419 | 304 | $0 (2024) |
| Neos Therapeutics, LP | $56,712 | 76 | $0 (2019) |
| Shire North American Group Inc | $36,484 | 92 | $0 (2018) |
| Tris Pharma Inc | $19,889 | 53 | $0 (2019) |
| Rhodes Pharmaceuticals L.P. | $18,994 | 26 | $0 (2019) |
| Otsuka America Pharmaceutical, Inc. | $6,820 | 9 | $0 (2024) |
| Corium, Inc. | $920.00 | 1 | $0 (2021) |
| UCB, Inc. | $594.58 | 25 | $0 (2024) |
| MDD US Operations, LLC | $185.77 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $59,987 | 108 | Supernus Pharmaceuticals, Inc. ($52,596) |
| 2023 | $52,729 | 82 | Supernus Pharmaceuticals, Inc. ($44,396) |
| 2022 | $65,756 | 100 | Supernus Pharmaceuticals, Inc. ($61,803) |
| 2021 | $33,408 | 37 | Supernus Pharmaceuticals, Inc. ($29,948) |
| 2020 | $66,422 | 85 | Ironshore Pharmaceuticals Inc. ($42,236) |
| 2019 | $155,823 | 287 | Ironshore Pharmaceuticals Inc. ($104,360) |
| 2018 | $86,418 | 153 | Neos Therapeutics, LP ($36,572) |
| 2017 | $52,313 | 104 | Rhodes Pharmaceuticals L.P. ($18,980) |
All Payment Transactions
956 individual payment records from CMS Open Payments — Page 1 of 39
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Otsuka America Pharmaceutical, Inc. | — | Travel and Lodging | Cash or cash equivalent | $47.59 | General |
| 12/17/2024 | Otsuka America Pharmaceutical, Inc. | — | Travel and Lodging | Cash or cash equivalent | $45.56 | General |
| 12/13/2024 | Otsuka America Pharmaceutical, Inc. | — | Consulting Fee | Cash or cash equivalent | $6,048.00 | General |
| 12/06/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $101.45 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 12/06/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $85.08 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 12/06/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $55.00 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 12/06/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $26.57 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 12/06/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $12.08 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 12/05/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Honoraria | Cash or cash equivalent | $7,130.00 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 12/05/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Travel and Lodging | In-kind items and services | $325.13 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 12/05/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $200.09 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 11/21/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Honoraria | Cash or cash equivalent | $2,280.00 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 11/20/2024 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $6.19 | General |
| Category: Neurology | ||||||
| 11/18/2024 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $7.07 | General |
| Category: Neurology | ||||||
| 11/15/2024 | Otsuka America Pharmaceutical, Inc. | — | Food and Beverage | In-kind items and services | $27.28 | General |
| 11/15/2024 | Otsuka America Pharmaceutical, Inc. | — | Food and Beverage | In-kind items and services | $20.46 | General |
| 11/15/2024 | Otsuka America Pharmaceutical, Inc. | — | Food and Beverage | In-kind items and services | $15.88 | General |
| 11/14/2024 | Otsuka America Pharmaceutical, Inc. | — | Travel and Lodging | In-kind items and services | $334.95 | General |
| 11/14/2024 | Otsuka America Pharmaceutical, Inc. | — | Travel and Lodging | In-kind items and services | $218.86 | General |
| 11/14/2024 | Otsuka America Pharmaceutical, Inc. | — | Food and Beverage | In-kind items and services | $61.38 | General |
| 11/03/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 11/03/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $14.18 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 10/30/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $20.76 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 10/16/2024 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $34.59 | General |
| Category: Neurology | ||||||
| 10/07/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $14.36 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
About Dr. Frank Lopez, MD
Dr. Frank Lopez, MD is a Neurodevelopmental Disabilities healthcare provider based in Winter Park, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/12/2007. The National Provider Identifier (NPI) number assigned to this provider is 1154453397.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Frank Lopez, MD has received a total of $572,854 in payments from pharmaceutical and medical device companies, with $59,987 received in 2024. These payments were reported across 956 transactions from 25 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($404,540).
Ad
Practice Information
- Specialty Neurodevelopmental Disabilities
- Location Winter Park, FL
- Active Since 03/12/2007
- Last Updated 07/09/2007
- Taxonomy Code 2080P0008X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1154453397
Products in Payments
- QELBREE (Drug) $106,235
- Jornay PM 20mg capsules (Bottle of 100) (Drug) $104,360
- Adzenys XR-ODT (Drug) $56,698
- JORNAY PM (Drug) $56,059
- Qelbree (Drug) $52,596
- MYDAYIS (Drug) $33,442
- Aptensio XR (Drug) $18,994
- Dyanavel XR (Drug) $18,365
- TROKENDI XR (Drug) $4,324
- Quillivant XR (Drug) $1,512
- Azstarys (Drug) $920.00
- Fintepla (Drug) $321.22
- MYOBLOC (Drug) $185.77
- VALTOCO (Drug) $154.94
- APTIOM (Drug) $151.88
- Briviact (Drug) $151.30
- EPIDIOLEX (Drug) $147.47
- Nayzilam (Drug) $122.06
- VYVANSE (Drug) $96.22
- VNS THERAPY SENTIVA MODEL 1000 GENERATOR (Device) $66.45
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.